tailieunhanh - CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy

Hepatocellular carcinoma (HCC) is one of the most fatal malignancies worldwide, and CD133 is a popular cancer stem cell (CSC) marker for HCC. CD133+ CSCs have been reported to resist conventional chemo- and radiotherapy, but little is known about their response to immune surveillance. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN